Clinical data | |
---|---|
Trade names | Rimadyl |
AHFS/Drugs.com | FDA Professional Drug Information |
License data | |
Routes of administration | By mouth, injection |
ATCvet code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | High (99%) |
Elimination half-life | Approximately 8 h (range 4.5–9.8 h) in dogs |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.357 |
Chemical and physical data | |
Formula | C15H12ClNO2 |
Molar mass | 273.72 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the carbazole and propionic acid class that was previously for use in humans and animals but is now only available to veterinarians for prescribing as a supportive treatment for various conditions in animals.[1] Carprofen reduces inflammation by inhibition of COX-1 and COX-2; its specificity for COX-2 varies from species to species.[1] Marketed under many brand names worldwide,[3] carprofen is used as a treatment for inflammation and pain, including joint pain and postoperative pain.[1]
Carprofen Orion EPAR
was invoked but never defined (see the help page).